Together, our findings suggest that LRG1 served as a negative regulator of the TGF-β1/SMAD 2/3 pathway, which impacted the EMT and migration and invasion of ESCC cells. The gene discussed is LRG1; the disease is esophageal squamous cell carcinoma.